← Open Payments lookup

KRISTIN ATTIOGBE: Open Payments

NPI 1699055749 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,928 in 119 payments from 19 companies in 2025. Trend: 2023 $6,756 · 2024 $20,573 · 2025 $12,928

Consulting: $7,033Food & beverage: $3,739Travel & lodging: $1,784Honoraria: $372
CompanyPaymentsAmount
Genentech USA, Inc.6$2,937
Takeda Pharmaceuticals U.S.A., Inc.16$2,530
Janssen Biotech, Inc.20$1,890
PFIZER INC.13$1,775
Celltrion USA Inc.3$1,280
ABBVIE INC.19$656
Merck Sharp & Dohme LLC6$575
Janssen Scientific Affairs, LLC2$250
Lilly USA, LLC7$247
GENZYME CORPORATION4$211

Products named: TREMFYA, VELSIPITY, ZYMFENTRA, RINVOQ, ENTYVIO, OMVOH, DUPIXENT, SKYRIZI.

Industry payments across MD — which companies pay providers there.